Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers

View/ Open
Author
Morris, Charles D.
Azadnia, Parisa
de Val, Natalia
Vora, Nemil
Honda, Andrew
Giang, Erick
Saye-Francisco, Karen
Cheng, Yushao
Lin, Xiaohe
Mann, Colin J.
Tang, Jeffrey
Sok, Devin
Burton, Dennis R.
Law, Mansun
Ward, Andrew B.
He, Linling
Zhu, Jiang
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1128/mBio.00036-17Metadata
Show full item recordCitation
Morris, C. D., P. Azadnia, N. de Val, N. Vora, A. Honda, E. Giang, K. Saye-Francisco, et al. 2017. “Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers.” mBio 8 (1): e00036-17. doi:10.1128/mBio.00036-17. http://dx.doi.org/10.1128/mBio.00036-17.Abstract
ABSTRACT Broadly neutralizing antibodies (bNAbs) have provided valuable insights into the humoral immune response to HIV-1. While rationally designed epitope scaffolds and well-folded gp140 trimers have been proposed as vaccine antigens, a comparative understanding of their antibody responses has not yet been established. In this study, we probed antibody responses to the N332 supersite and the membrane-proximal external region (MPER) in the context of heterologous protein scaffolds and native-like gp140 trimers. Ferritin nanoparticles and fragment crystallizable (Fc) regions were utilized as multivalent carriers to display scaffold antigens with grafted N332 and MPER epitopes, respectively. Trimeric scaffolds were also identified to stabilize the MPER-containing BG505 gp140.681 trimer in a native-like conformation. Following structural and antigenic evaluation, a subset of scaffold and trimer antigens was selected for immunization in BALB/c mice. Serum binding revealed distinct patterns of antibody responses to these two bNAb targets presented in different structural contexts. For example, the N332 nanoparticles elicited glycan epitope-specific antibody responses that could also recognize the native trimer, while a scaffolded BG505 gp140.681 trimer generated a stronger and more rapid antibody response to the trimer apex than its parent gp140.664 trimer. Furthermore, next-generation sequencing (NGS) of mouse splenic B cells revealed expansion of antibody lineages with long heavy-chain complementarity-determining region 3 (HCDR3) loops upon activation by MPER scaffolds, in contrast to the steady repertoires primed by N332 nanoparticles and a soluble gp140.664 trimer. These findings will facilitate the future development of a coherent vaccination strategy that combines both epitope-focused and trimer-based approaches.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347340/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:32071986
Collections
- HMS Scholarly Articles [17298]
Contact administrator regarding this item (to report mistakes or request changes)